These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 34038042)
1. Ginsenoside Rg3 suppresses ovarian cancer cell proliferation and invasion by inhibiting the expression of lncRNA H19. Zhao L; Sun W; Zheng A; Zhang Y; Fang C; Zhang P Acta Biochim Pol; 2021 May; 68(4):575-582. PubMed ID: 34038042 [TBL] [Abstract][Full Text] [Related]
2. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells. Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782 [TBL] [Abstract][Full Text] [Related]
3. Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic. Pu Z; Ge F; Wang Y; Jiang Z; Zhu S; Qin S; Dai Q; Liu H; Hua H Bioengineered; 2021 Dec; 12(1):2398-2409. PubMed ID: 34130594 [TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg3 alleviates the migration, invasion, and angiogenesis of lung cancer cells by inhibiting the expressions of cyclooxygenase-2 and vascular endothelial growth factor. Lv Q; Xia Z; Huang Y; Ruan Z; Wang J; Huang Z Chem Biol Drug Des; 2023 Apr; 101(4):937-951. PubMed ID: 36593682 [TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg3 inhibits the malignant progression of cervical cancer cell by regulating AKT2 expression. Liu H; Xie T; Liu Y Heliyon; 2023 Aug; 9(8):e19045. PubMed ID: 37664735 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA-H19 promotes ovarian cancer cell proliferation and migration via the microRNA-140/Wnt1 axis. Wang Y; Gao WJ Kaohsiung J Med Sci; 2021 Sep; 37(9):768-775. PubMed ID: 34002485 [TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1. Li J; Qi Y Exp Mol Pathol; 2019 Feb; 106():131-138. PubMed ID: 30633886 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA H19 promotes the proliferation and invasion of lung cancer cells and regulates the expression of E-cadherin, N-cadherin, and vimentin. Liao S; Yu C; Liu H; Zhang C; Li Y; Zhong X Onco Targets Ther; 2019; 12():4099-4107. PubMed ID: 31190899 [TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rd inhibits migration and invasion of tongue cancer cells through H19/miR-675-5p/CDH1 axis. Chang L; Wang D; Kan S; Hao M; Liu H; Yang Z; Xia Q; Liu W J Appl Oral Sci; 2022; 30():e20220144. PubMed ID: 36074434 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA H19 correlates with unfavorable prognosis and promotes cell migration and invasion in ovarian cancer. Ma H; Gao L; Yu H; Song X Ginekol Pol; 2022 Jan; ():. PubMed ID: 35072217 [TBL] [Abstract][Full Text] [Related]
11. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway. Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA H19 mediates ovarian cancer cell cisplatin-resistance and migration during EMT. Wu Y; Zhou Y; He J; Sun H; Jin Z Int J Clin Exp Pathol; 2019; 12(7):2506-2515. PubMed ID: 31934077 [TBL] [Abstract][Full Text] [Related]
13. Ginsenoside 20(S)-Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer. Zheng X; Chen W; Hou H; Li J; Li H; Sun X; Zhao L; Li X Biomed Pharmacother; 2017 Jan; 85():620-626. PubMed ID: 27899249 [TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg3 inhibits osteosarcoma progression by reducing circ_0003074 expression in a miR-516b-5p/KPNA4-dependent manner. Wang T; Zhang C; Wang S J Orthop Surg Res; 2021 Dec; 16(1):724. PubMed ID: 34930332 [TBL] [Abstract][Full Text] [Related]
15. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer. Hao T; Huang S; Han F Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404 [TBL] [Abstract][Full Text] [Related]
16. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912 [TBL] [Abstract][Full Text] [Related]
17. Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells. Zhao L; Shou H; Chen L; Gao W; Fang C; Zhang P Oncol Rep; 2019 Jun; 41(6):3209-3218. PubMed ID: 31002353 [TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 Reduces Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β1 by Inactivation of AKT in HMrSV5 Peritoneal Mesothelial Cells. Yan X; Zhang W; Kong F; Li Q; Shan W; Zhang C; Han T; Che Y; Zhang Y Med Sci Monit; 2019 Sep; 25():6972-6979. PubMed ID: 31527568 [TBL] [Abstract][Full Text] [Related]
19. [Ginsenoside Rg3 Regulates Cisplatin Resistance in Gastric Cancer by Wnt/β-catenin Signaling Pathway]. Meng ZQ; Zhang R; Wu XW; Jin TF; Zhang MH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):366-376. PubMed ID: 35791931 [TBL] [Abstract][Full Text] [Related]
20. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway. Ma N; Zhao Y Cell Biochem Funct; 2020 Aug; 38(6):801-809. PubMed ID: 32424818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]